Immediate Impact

72 standout
Sub-graph 1 of 21

Citing Papers

Global burden of MAFLD, MAFLD related cirrhosis and MASH related liver cancer from 1990 to 2021
2025 Standout
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
2025 Standout
2 intermediate papers

Works of Jie‐Jun Hu being referenced

Nonalcoholic fatty liver disease and mortality from all causes, cardiovascular disease, and cancer: a meta-analysis
2019

Author Peers

Author Last Decade Papers Cites
Jie‐Jun Hu 71 68 68 150 120 22 434
Horațiu Silaghi 113 60 25 140 146 29 502
Yunyang Deng 56 30 65 128 81 29 385
R Erwald 46 66 63 89 38 28 421
Chunhua Lin 163 43 23 180 83 31 454
Katsuhisa Toda 88 22 27 101 62 19 441
Monia Dall’Agata 84 72 52 124 32 20 447
Clarissa Elysia Fu 42 40 20 245 101 19 376
Vaihere Delaune 95 17 26 202 121 24 443
Kathryn Jean Lucas 98 35 30 209 183 21 462
Rong Luo 98 42 57 81 91 24 445

All Works

Loading papers...

Rankless by CCL
2026